BC-ADM Exam Questions Exam (2026)
Exam Questions & Answers | Latest
Already Graded A+ UPDATE 2025|2026
Contributors to therapeutic Inertia - Clinician related -
,,,,,,ANSWER,,,,,,,time constraints and competing priorities
failing to set and use glycemic targets and goals to initiate, evaluated or
intensity treatment
concerns with treatment SE (hypoglycemia)
underestimating patient self-management needs and abilities
underutilizing MNT and DSMES
Contributors to therapeutic Inertia - Patient related -
,,,,,,ANSWER,,,,,,,Cost and access to medication
Social determinants of health
Limited understanding of the progressive nature of DM and need for
treatment to change with time
Poor access and low participation in DM education and MNT
Poor communication/trust with provider/health system
Contributors to therapeutic Inertia - System related -
,,,,,,ANSWER,,,,,,,Cost of meds
Failing to ID therapeutic inertia
Lack of transparency or accuracy in formulary options
Not providing and promoting access to DSMES
No team approach to care
What are the practical benefits of pump basal delivery -
,,,,,,ANSWER,,,,,,,stable BG between meals and overnight
can skip/delay meals without risk of hypogly
can vary sleep and work schedule
, fewer issues when traveling
can correct for dawn phenomenon
no long acting insulin
immediate, temp basal adjustments possible
makes hybrid close loop automation possible
What does HCL stand for - ,,,,,,ANSWER,,,,,,,hybrid close loop
What are the practical benefits of bolusing with a pump -
,,,,,,ANSWER,,,,,,,Fewer injections
can dose very precisely (0.05u)
convenient to give insulin anytime
built in bolus calcuator
unused insulin adjustment prevents dose stacking
rate of delivery can be extended
insulin delivery history stored in pump
Limitation of insulin pump therapy - ,,,,,,ANSWER,,,,,,,out of pocket
cost
user still has to complete BG monitoring and carb counting
learning curve
weight gain
wearing device
adhesion and skin irritation
alarm/alert fatigue
time/discomfort on set changes
teaching and follow up
CI to insulin pump therapy - ,,,,,,ANSWER,,,,,,,unwilling to monitor BG
tenuous relationship with HCP
physically unable to use/maintain pump safely
occupation that prohibits use
environment unsuitable for insulin stability
severe allergies to materials in pump or devices
Exam Questions & Answers | Latest
Already Graded A+ UPDATE 2025|2026
Contributors to therapeutic Inertia - Clinician related -
,,,,,,ANSWER,,,,,,,time constraints and competing priorities
failing to set and use glycemic targets and goals to initiate, evaluated or
intensity treatment
concerns with treatment SE (hypoglycemia)
underestimating patient self-management needs and abilities
underutilizing MNT and DSMES
Contributors to therapeutic Inertia - Patient related -
,,,,,,ANSWER,,,,,,,Cost and access to medication
Social determinants of health
Limited understanding of the progressive nature of DM and need for
treatment to change with time
Poor access and low participation in DM education and MNT
Poor communication/trust with provider/health system
Contributors to therapeutic Inertia - System related -
,,,,,,ANSWER,,,,,,,Cost of meds
Failing to ID therapeutic inertia
Lack of transparency or accuracy in formulary options
Not providing and promoting access to DSMES
No team approach to care
What are the practical benefits of pump basal delivery -
,,,,,,ANSWER,,,,,,,stable BG between meals and overnight
can skip/delay meals without risk of hypogly
can vary sleep and work schedule
, fewer issues when traveling
can correct for dawn phenomenon
no long acting insulin
immediate, temp basal adjustments possible
makes hybrid close loop automation possible
What does HCL stand for - ,,,,,,ANSWER,,,,,,,hybrid close loop
What are the practical benefits of bolusing with a pump -
,,,,,,ANSWER,,,,,,,Fewer injections
can dose very precisely (0.05u)
convenient to give insulin anytime
built in bolus calcuator
unused insulin adjustment prevents dose stacking
rate of delivery can be extended
insulin delivery history stored in pump
Limitation of insulin pump therapy - ,,,,,,ANSWER,,,,,,,out of pocket
cost
user still has to complete BG monitoring and carb counting
learning curve
weight gain
wearing device
adhesion and skin irritation
alarm/alert fatigue
time/discomfort on set changes
teaching and follow up
CI to insulin pump therapy - ,,,,,,ANSWER,,,,,,,unwilling to monitor BG
tenuous relationship with HCP
physically unable to use/maintain pump safely
occupation that prohibits use
environment unsuitable for insulin stability
severe allergies to materials in pump or devices
